While the medication itself has a low risk of causing hypoglycemia in people without type 2 diabetes, adding aspirin can potentially amplify this effect
Clinical trials show that patients using Ozempic (semaglutide) lose on average around 15% of their body weight over 1218 months (STEP 1 trial)
Key differences include pharmacy classification (Empower operates as both 503A and 503B), geographic footprint, and the specific telehealth platforms each works with
Dosage should be individualized to obtain an adequate response (in this case, appetite suppression) with the lowest effective dose
Ethical factors clarify treatment goals and ensure we meet legal standards
Since GLP-1 receptor agonists , like Mounjaro and Zepbound , have been linked to hair thinning , understanding the connection between weight loss drugs and hair loss is essential